Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events

被引:24
作者
Simon, Tobias [1 ]
Becker, Ruediger [1 ]
Voss, Frederik [1 ]
Bikou, Olympia [1 ]
Hauck, Melanie [1 ]
Licka, Manuela [1 ]
Katus, Hugo A. [1 ]
Bauer, Alexander [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Cardiol, D-69120 Heidelberg, Germany
关键词
nonischemic cardiomyopathy; risk stratification; non sustained ventricular tachycardias; NT-pro BNP; sudden cardiac death;
D O I
10.1007/s00392-007-0629-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with nonischemic cardiomyopathy (DCM) are at high risk for sudden cardiac death (SCD). However, the predictive value of prophylactic implantation of implantable cardioverter defibrillators (ICD) in this patient cohort is yet unclear. Methods and Results: Whether NT pro BNP levels and/or reproducible non sustained ventricular tachycardias (NSVTs) are predictive for SCD was prospectively tested in 30 patients with DCM and LVEF <= 40%. All patients received Holter-recordings (HR) on three consecutive days and baseline NT-pro BNP levels were determined. Patients were followed for occurrence of ventricular tachyarrhythmias or unexplained syncope. A great degree of variability was found regarding the occurrence of NSVTs (10% had NSVTs in two consecutive HR, 10% in three consecutive HR, 30% in one HR and 50% had no NSVTs). Patients with NSVTs in more than one HR had significantly higher NT-pro BNP levels (first quartile: 715 pg/ml, median 2,176 pg/ml, third quartile 5,755 pg/ml vs. first quartile 273 pg/ml, median 566 pg/ml, third quartile 1,350 pg/ml, P = 0.0388). During a mean follow-up of 21.6 +/- 1.2 months patients with an arrhythmic event had significantly higher NT-pro BNP levels than patients without event (first quartile: 1,002 pg/ml, median 4,075 pg/ml, third quartile 7,777 pg/ml vs. first quartile 173 pg/ml, median 267 pg/ml, third quartile 1,220 pg/ml, P = 0.0135). NT-pro BNP levels of 2,259 pg/ml were identified as optimal cut-off value for the prediction of arrhythmic events (P = 0.0313). In contrast reproducible NSVTs were not predictive for arrhythmic events (P = 0.0960). Conclusion: The present study demonstrates that in patients with DCM the value of reproducible NSVTs in predicting arrhythmic events is low. In contrast raised NT-pro BNP levels significantly correlated with occurrence of symptomatic ventricular arrhythmias. Larger prospective trials are required to confirm these results.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 13 条
[1]   Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy -: The cardiomyopathy trial (CAT) [J].
Bänsch, D ;
Antz, M ;
Boczor, S ;
Volkmer, M ;
Tebbenjohanns, J ;
Seidl, K ;
Block, M ;
Gietzen, F ;
Berger, J ;
Kuck, KH .
CIRCULATION, 2002, 105 (12) :1453-1458
[2]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[3]   Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy [J].
Becker, R ;
Haass, M ;
Ick, D ;
Krueger, C ;
Bauer, A ;
Senges-Becker, JC ;
Voss, F ;
Hilbel, T ;
Niroomand, F ;
Katus, HA ;
Schoels, W .
BASIC RESEARCH IN CARDIOLOGY, 2003, 98 (04) :259-266
[4]   B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].
Berger, R ;
Huelsman, M ;
Strecker, K ;
Bojic, A ;
Moser, P ;
Stanek, B ;
Pacher, R .
CIRCULATION, 2002, 105 (20) :2392-2397
[5]  
Böhm M, 2006, CLIN RES CARDIOL, V95, P36, DOI 10.1007/s00392-006-2008-9
[6]   A randomized study of the prevention of sudden death in patients with coronary artery disease [J].
Buxton, AE ;
Lee, KL ;
Fisher, JD ;
Josephson, ME ;
Prystowsky, EN ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1882-1890
[7]   Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour Holter electrocardiography [J].
Grimm, W ;
Glaveris, C ;
Hoffmann, J ;
Menz, V ;
Müller, HH ;
Hufnagel, G ;
Maisch, B .
AMERICAN HEART JOURNAL, 2000, 140 (01) :43-51
[8]   Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy [J].
Kadish, A ;
Dyer, A ;
Daubert, JP ;
Quigg, R ;
Estes, NAM ;
Anderson, KP ;
Calkins, H ;
Hoch, D ;
Goldberger, J ;
Shalaby, A ;
Sanders, WE ;
Schaechter, A ;
Levine, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2151-2158
[9]   Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy [J].
Klingenberg, R. ;
Zugck, C. ;
Becker, R. ;
Schellberg, D. ;
Heinze, G. ;
Kell, R. ;
Remppis, A. ;
Schoels, W. ;
Katus, H. A. ;
Dengler, T. J. .
HEART, 2006, 92 (09) :1323-1324
[10]   Diagnosing syncope .2. Unexplained syncope [J].
Linzer, M ;
Yang, EH ;
Estes, NAM ;
Wang, P ;
Vorperian, VR ;
Kapoor, WN .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (01) :76-86